RxDoctor Payments Data

Casey Holmes, MD

Plastic Surgery · Naples, FLNPI 1720387061

Payments from drug & device makers

What this record shows

This record is dominated by other: $7,577 of the $11,701 with a category attached, or 64.8%. Integra Lifesciences Corporation accounts for 66.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $7,863 and has fallen 84.5% since, to $1,216 in 2025.

$11,701in general payments, 2019–2025

Across 101 payments — averaging $115.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$8K
  • AbbVie$2K
  • TELA Bio, Inc.$761
  • Endo Pharmaceuticals Inc.$216
  • Axogen$210
  • Acelrx Pharmaceuticals, Inc.$104
  • plus $345 from 7 others
$15,950in research payments, 2019–2025

Across 1 payment — averaging $15,950 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • TELA Bio, Inc.$16K

What the payments were for

  • Consulting fees$7006%
  • Travel & lodging$881%
  • Food & beverage$3,25228%
  • Education$851%
  • Other$7,57765%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,701 in reported general payments places this provider in the 85th percentile of 456 plastic surgery providers in Florida.

See all plastic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$177,498
Medicare patients
140
Services billed
623

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate147$1,370
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen69$366
ValacyclovirValacyclovir Hcl12$244
Ondansetron Hcl23$150
Gabapentin25$81
Zolpidem Tartrate16$73
Ciprofloxacin Hcl12$71
Dexamethasone13$54
Diazepam24$43

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Naples

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →